Showing results (1161-1170 of 3,153) with videos related to

Sort By:
Pageof 316
Neuro-Oncology|October 31, 2019
Metabolic reprogramming associated with aggressiveness occurs in the G-CIMP-high molecular subtypes of IDH1mut lower grade gliomasVictor Ruiz-Rodado, Tathiane M Malta, Tomohiro Seki, et al.
Neuro-Oncology|February 18, 2020
ALCAM contributes to brain metastasis formation in non-small-cell lung cancer through interaction with the vascular endotheliumJustine Münsterberg, Desirée Loreth, Laura Brylka, et al.
Neuro-Oncology|January 21, 2020
Use of radiomics for the prediction of local control of brain metastases after stereotactic radiosurgeryAndrei Mouraviev, Jay Detsky, Arjun Sahgal, et al.
Neuro-Oncology|January 9, 2020
SWI/SNF complex heterogeneity is related to polyphenotypic differentiation, prognosis, and immune response in rhabdoid tumorsPooja Panwalkar, Drew Pratt, Chan Chung, et al.
Neuro-Oncology|February 5, 2019
The RANO Leptomeningeal Metastasis Group proposal to assess response to treatment: lack of feasibility and clinical utility and a revised proposalEmilie Le Rhun, Patrick Devos, Thomas Boulanger, et al.
Neuro-Oncology|February 7, 2019
Cystathionine as a marker for 1p/19q codeleted gliomas by in vivo magnetic resonance spectroscopyFrancesca Branzoli, Clément Pontoizeau, Lucien Tchara, et al.
Neuro-Oncology|February 7, 2019
Stereotactic radiosurgery with concurrent HER2-directed therapy is associated with improved objective response for breast cancer brain metastasisJoseph M Kim, Jacob A Miller, Rupesh Kotecha, et al.
Neuro-Oncology|January 23, 2019
Modulation of temozolomide dose differentially affects T-cell response to immune checkpoint inhibitionAida Karachi, Changlin Yang, Farhad Dastmalchi, et al.
Neuro-Oncology|January 23, 2019
Intratumor DNA methylation heterogeneity in glioblastoma: implications for DNA methylation-based classificationAnna Wenger, Sandra Ferreyra Vega, Teresia Kling, et al.
Neuro-Oncology|February 13, 2019
Phase I/II trial testing safety and immunogenicity of the multipeptide IMA950/poly-ICLC vaccine in newly diagnosed adult malignant astrocytoma patientsDenis Migliorini, Valérie Dutoit, Mathilde Allard, et al.
Pageof 316